Pancreatic Cancer Research

ResearcherPrecision Biologics, IncNo recent work listed

Philip Martin Arlen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5073536820. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
2
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 trial · 2013: 1 trial · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal A… Co-author DOI 10.1001/jamanetworkopen.2022.49720↗
  2. A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer. Co-author DOI 10.1007/s00280-016-3108-5↗

Trials 2

  1. QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer Study director NCT01834235↗
  2. QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Study director NCT01040000↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Shaalan Beg · 2 shared papers, 2016–2023 · strength 0.21
  2. Michael Andrew Morse · 2 shared papers, 2016–2023 · strength 0.21
  3. Janet E. Murphy · 1 shared paper, 2023 · strength 0.15
  4. Hanna Kelly Sanoff · 1 shared paper, 2023 · strength 0.15
  5. Atrayee Basu Mallick · 1 shared paper, 2023 · strength 0.15
  6. Peter J. Hosein · 1 shared paper, 2023 · strength 0.15
  7. Brian Matthew Wolpin · 1 shared paper, 2023 · strength 0.15
  8. Brandon M. Huffman · 1 shared paper, 2023 · strength 0.15
  9. Jill Lacy · 1 shared paper, 2023 · strength 0.15
  10. Andrea Wang‐Gillam · 1 shared paper, 2023 · strength 0.15
  11. James M. Cleary · 1 shared paper, 2023 · strength 0.15
  12. Nilofer Saba Azad · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.